Neko Health, a leading provider of artificial intelligence-powered healthcare services, has unveiled a multi-billion dollar expansion plan for its clinic-based diagnostic platform. The company, which focuses on preventive screening and early detection through AI-driven medical imaging and blood tests, plans to deploy its technology in major cities across the United States starting with New York.
Neko Health's cutting-edge solution combines medical imaging, proprietary sensors, and clinician review to provide comprehensive patient care. This new expansion is part of a larger effort by the company to further revolutionize healthcare delivery, leveraging AI to identify potential health risks earlier and more accurately than traditional methods. The investment in the US market represents Neko Health's growing presence in the country.
The Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, a well-established venture capital firm that has backed numerous prominent healthcare technology startups. As part of this new funding, existing investors will participate in expanding Neko Health's operations, product offerings, and global reach. The company plans to continue investing heavily in its AI-powered diagnostic platform, pushing the boundaries of medical innovation and improving patient outcomes across the US.